Acurx Pharmaceuticals Inc (NASDAQ: ACXP) on Monday, soared 38.01% from the previous trading day, before settling in for the closing price of $3.21. Within the past 52 weeks, ACXP’s price has moved between $3.17 and $25.00.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -7.84%. The company achieved an average annual earnings per share of 67.24%. With a float of $1.92 million, this company’s outstanding shares have now reached $2.09 million.
Acurx Pharmaceuticals Inc (ACXP) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Acurx Pharmaceuticals Inc is 8.12%, while institutional ownership is 3.04%. The most recent insider transaction that took place on Jan 06 ’25, was worth 25,000. In this transaction Director of this company bought 24,631 shares at a rate of $1.01, taking the stock ownership to the 27,708 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Director bought 24,631 for $1.01, making the entire transaction worth $25,000. This insider now owns 137,183 shares in total.
Acurx Pharmaceuticals Inc (ACXP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 67.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.37% during the next five years compared to -7.84% drop over the previous five years of trading.
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Trading Performance Indicators
Acurx Pharmaceuticals Inc (ACXP) is currently performing well based on its current performance indicators. A quick ratio of 2.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.52, a number that is poised to hit -1.01 in the next quarter and is forecasted to reach -3.80 in one year’s time.
Technical Analysis of Acurx Pharmaceuticals Inc (ACXP)
The latest stats from [Acurx Pharmaceuticals Inc, ACXP] show that its last 5-days average volume of 0.18 million was inferior to 0.26 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.24%.
During the past 100 days, Acurx Pharmaceuticals Inc’s (ACXP) raw stochastic average was set at 18.54%, which indicates a significant decrease from 88.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.19, while its 200-day Moving Average is $7.05. Now, the first resistance to watch is $4.94. This is followed by the second major resistance level at $5.45. The third major resistance level sits at $6.30. If the price goes on to break the first support level at $3.58, it is likely to go to the next support level at $2.73. The third support level lies at $2.22 if the price breaches the second support level.
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Key Stats
Market capitalization of the company is 9.23 million based on 2,085K outstanding shares. Right now, sales total 0 K and income totals -14,100 K. The company made 0 K in profit during its latest quarter, and -1,990 K in sales during its previous quarter.
